Research has shown reveals that TGF-β signaling induces transcriptional repression of miR-203 through direct binding of SNAI2 to the miR-203 promoter, thereby promoting EMT and metastatic progression in breast cancer (Ding et al., 2013). Here, TGFB1 is linked to breast carcinoma.